Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
More than 100 million Americans have prediabetes or diabetes. Prediabetes is a condition in which individuals have blood glucose levels higher than normal but not high enough to be classified as diabetes. People with prediabetes have an increased risk of Type 2 diabetes. An estimated 34% of adults have prediabetes. Prediabetes is now recognized as a reversible condition that increases an individual's risk for development of diabetes. Lifestyle risk factors for prediabetes include overweight and physical inactivity.Increasing awareness and risk stratification of individuals with prediabetes may help physicians understand potential interventions that may help decrease the percentage of patients in their panels in whom diabetes develops. If untreated, 37% of the individuals with prediabetes may have diabetes in 4 years. Lifestyle intervention may decrease the percentage of prediabetic patients in whom diabetes develops to 20%.Long-term data also suggest that lifestyle intervention may decrease the risk of prediabetes progressing to diabetes for as long as 10 years. To prevent 1 case of diabetes during a 3-year period, 6.9 persons would have to participate in the lifestyle intervention program. In addition, recent data suggest that the difference in direct and indirect costs to care for a patient with prediabetes vs a patient with diabetes may be as much as $7000 per year. Investment in a diabetes prevention program now may have a substantial return on investment in the future and help prevent a preventable disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have demonstrated that weight loss and exercise can usually delay progression to T2D, or even prevent T2D from manifesting; lifestyle interventions reduce the risk of T2D progression in 40–70% of adults with prediabetes.91,92”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [92]
In the citing paper
“Reducing demand on the islet beta-cells by improving insulin sensitivity through weight loss and/or pharmacological means has been reported to improve T2D prognosis and delay/prevent pre-diabetic individuals progressing to T2D, suggesting that inducing “beta-cell rest” to even a degree alleviates the pathology that is associated with this disease.92,98”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [92]
In the citing paper
“Reducing demand on the islet beta-cells by improving insulin sensitivity through weight loss and/or pharmacological means has been reported to improve T2D prognosis and delay/prevent pre-diabetic individuals progressing to T2D, suggesting that inducing “beta-cell rest” to even a degree alleviates the pathology that is associated with this disease.92,98”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [92]
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Cited by
Items 101–200 of 251
Chen, Y., Wang, Y., Xu, K., Zhou, J., Yu, L., Wang, N., Liu, T., & Fu, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111481 · Cited by 10
Brinkmann, C. K., Hof, H., Gysan, D.-B., Albus, C., Millentrup, S., Bjarnason‐Wehrens, B., Latsch, J., Herold, G., Wegscheider, K., Heming, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106334 · Cited by 15
Chung, R., Chuang, S., Chen, Y., Li, G.-H., Hsieh, C., Chiou, H., & Hsiung, C. A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003423 · Cited by 11
Concurrent Prediabetes and Prehypertension in a Rural Community in South East Nigeria
Nwatu, C. B., Young, E. E., Okwara, C., Okoli, C., Obi, P., Anyim, O. B., Ubani, B. C., Okafor, C. I., & Oli, J. (2017) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2017/34226 · Cited by 9
“Left untreated, up to 70% of individuals with prediabetes may eventually progress to frank diabetes if followed up for up to five years or more [1,9].”
BackgroundCosta‐Urrutia, P., Abud, C., Franco‐Trecu, V., Colistro, V., Rodríguez-Arellano, M. E., Granados, J., & Seelaender, M. C. L. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.005 · Cited by 10
Prediabetes: Adherence to Nutrition Visits Decreases HbA1c in Children and Adolescents
Parajuli, S., Jasmin, G., Sirak, H., Lee, A. F. S., & Nwosu, B. U. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.916785 · Cited by 9
“prediabetes to T2D from 37% to 20% over a 4-year period (8).”
BackgroundNwosu, B. U. (2022) · Endocrines · doi:10.3390/endocrines3030045 · Cited by 10
“The reported prevalence of prediabetes in studies could vary as a result of the parameters used for its definition [3,6].”
BackgroundCurrent analytical methods to monitor type 2 diabetes medication in biological samples
Rakusanova, S., & Čajka, T. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116831 · Cited by 10
Red Cell Distribution Width and Prediabetes in Adults in Northern Sudan: A Case–Control Study
Hassan, A. A., Ahmed, B. E., & Adam, I. (2023) · Hematology Reports · doi:10.3390/hematolrep15040066 · Cited by 9
Teoh, K. W., Ng, C. M., Chong, C. W., Cheong, W. L., Ng, Y. L., Bell, J. S., & Lee, S. W. H. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-083921 · Cited by 13
An Expert Group Consensus Statement on “Approach and Management of Prediabetes in India”
Das, A. K., Mohan, V., Ramachandran, A., Kalra, S., Mithal, A., Sahay, R. K., TIWASKAR, M. H., Das, S., Baruah, M. P., Jacob, J. J., et al. (2022) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0162 · Cited by 12
Sosibo, A. M., Mzimela, N. C., Ngubane, P. S., & Khathi, A. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.10.004 · Cited by 14
Liberty, I. A., Kodim, N., Sartika, R. A. D., Trihandini, I., Tjekyan, R. M. S., Zulkarnain, Pane, M., Pratisthita, L. B., Tahapary, D. L., & Soewondo, P. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102280 · Cited by 8
Saboo, N., Kacker, S., & Rathore, J. (2021) · International Journal of Yoga · doi:10.4103/ijoy.ijoy_74_21 · Cited by 9
Digital technologies for prediabetes: A systematic review and meta-analysis
Ng, C. M., Cheong, W. L., Chong, C. W., Teoh, S. L., Yap, W. S., & Lee, S. W. H. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103206 · Cited by 7
Saboo, N., & Kacker, S. (2024) · Annals of African Medicine · doi:10.4103/aam.aam_56_23 · Cited by 8
The interplay between vitamin D status, subclinical inflammation, and prediabetes
Arabi, A., Nasrallah, D., Mohsen, S., Abugharbieh, L., Al-Hashimi, D., AlMass, S., Albasti, S., Al-Ajmi, S. A., & Zughaier, S. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35764 · Cited by 15
“Prediabetes is identified as a pivotal juncture, given the empirical evidence suggesting the condition ’ s reversibility at this stage, providing a feasible avenue to mitigate and prevent the onset of diabetes mellitus [106,107].”
BackgroundTeoh, K. W., Baek, Y., Ademi, Z., & Lee, S. W. H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16350 · Cited by 9
“4 Characterized by both impaired fasting glucose and impaired glucose tolerance, individuals with prediabetes have elevated blood glucose levels above normal but remain below the threshold for a diagnosis of diabetes.”
Song, Y., Wang, H., Qin, L., Li, M., Gao, S., Wu, L., & Liu, T. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3628036 · Cited by 8
“To be more specific, nearly 10% of people with IFG and IGTprogress to diabetes every year [8], and the recent research suggests that 93% of subjects with prediabetes may develop diabetes within 20 years without active intervention [9].”
BackgroundKONES, R. J., & Rumana, U. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1421395 · Cited by 8
“tobacco use, and moderate intake of alcohol [198,199].”
BackgroundCurrent and emerging pharmacotherapy for prediabetes: are we moving forward?
Mangan, A., Docherty, N. G., le Roux, C. W., & Al‐Najim, W. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1517155 · Cited by 9
Umeizudike, K. A., Nwhator, S. O., Olayiwola, O., Ogundana, A. C., Räisänen, I. T., Fasanmade, O. A., Ogundana, O. M., Ajie, O. I., & Sorsa, T. A. (2025) · Biomedicines · doi:10.3390/biomedicines13040969 · Cited by 6
“…dentistry and the medical laboratory, in the provision of holistic care to patients living with prediabetes and diabetes, through early intervention. the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.”
Prediabetes in adult Saudis: a systematic review & meta-analysis of prevalence studies (2000–2024)
Mohieldein, A., Baig, H. A., Elhabiby, M. I., Almushawwah, A., Mahfouz, M. S., Khirelsied, A. H., Abdelmarouf, N., & Modawe, G. A. (2025) · PeerJ · doi:10.7717/peerj.19778 · Cited by 11
“A clearer understanding of the pooled prevalence of prediabetes is essential for assessing the effectiveness of intervention strategies and guiding future prevention efforts ( Tuso, 2014 ).”
Sandhu, S., Houlston, E., Dhadwal, A. S., & Yonel, Z. (2025) · Current Oral Health Reports · doi:10.1007/s40496-025-00420-8 · Cited by 7
“NDH is reversible and progression to T2DM is preventable [26].”
Chauhan, A., Semwal, D. K., Semwal, R. B., Joshi, S. K., Adhana, R. K., & Goswami, M. S. (2022) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/ayu.ayu_7_20 · Cited by 9
“It emphasized diet habits by including fiber in food and physical exercise can help to reduce blood glucose levels.[79]”
BackgroundHosseini, S., Bahadoran, Z., Mirmiran, P., & Azizi, F. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01356-5 · Cited by 7
“Prediabetes (Pre-DM) is a transitional hyperglycemic state that can return to normal glycemia or progress to type 2 diabetes (T2D) [1 , 2 ].”
Interdisciplinary Care Model: Diabetes and Oral Health
Shimpi, N. A., Ashton, J. L., Sorenson, C. A., Danial, L. O., O’Brien, J., Melms, W. F., & Acharya, A. (2018) · Health informatics · doi:10.1007/978-3-319-98298-4_4 · Cited by 6
Fong, T. C. T. (2019) · Obesity Facts · doi:10.1159/000500422 · Cited by 6
Muhammed, A. A., Taj, A., Ahmed, M. U., & Tabrez, E. S. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.3.57 · Cited by 7
Maor, M., Ataika, M., Shvartzman, P., & Lavie‐Ajayi, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010159 · Cited by 6
“Culturally relevant and accessible knowledge is key for both early detection and treatment as the participation in low-cost accessible lifestyle modification programs is one of the most effective indicators of successful treatment outcomes [1,2].”
BackgroundInfluentialŐri, Z., & Ori, I. (2016) · IEEE Global Humanitarian Technology Conference (GHTC) · doi:10.1109/ghtc.2016.7857334 · Cited by 6
“According to recent commentary [9], such tracking and an accompanying weight management program in primary care would significantly benefit patients with pre-diabetes.”
BackgroundVassou, C., D'Cunha, N., Naumovski, N., & Panagiotakos, D. (2020) · Journal of Diabetes and Metabolic Disorders · doi:10.1007/s40200-020-00551-y · Cited by 3
“According to recent data, approximately 35% of the adult population has intermediate hyperglycemia [1] and about 422 million people develop type II diabetes [2].”
BackgroundHalim, A. M., Sirajuddin, S., Bahar, B., Jafar, N., Syam, A., & Masni (2020) · Enfermería Clínica · doi:10.1016/j.enfcli.2019.10.081 · Cited by 6
Siddiqui, S., Zainal, H., Harun, S. N., & Ghadzi, S. M. S. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.06.022 · Cited by 8
Sosibo, A. M., Mzimela, N. C., Ngubane, P. S., & Khathi, A. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01363-z · Cited by 5
“Neverthe-less, T2DM will often be preceded by pre-diabetes [4, 5].”
Suhaimi, S. Q. A., Azemi, A. K., Mokhtar, S. S., Zin, A. A. M., & Rasool, A. H. G. (2025) · Nutrition · doi:10.1016/j.nut.2025.112692 · Cited by 8
Abdullah, K., Jacob, S., Hussain, H. Y., & Salim, N. A. (2019) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000500913 · Cited by 5
Role of Panchatikta Panchaprasutik Niruha Vasti in Prediabetes A case report
Ashtankar, P., & Sawarkar, P. G. (2020) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v11i3.1545 · Cited by 5
Ho, Y.-C. L., Lee, V. S. Y., Ho, M. R., Lin, G. J., & Thumboo, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010907 · Cited by 6
Shrestha, A., Suwal, R., Adhikari, S., Shrestha, N., Shrestha, B., & Khatri, B. (2023) · Journal of Nepal Medical Association · doi:10.31729/jnma.8118 · Cited by 6
Bermúdez, V., & Salazar, J. J. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000683 · Cited by 7
“Identification of patients with IFG is clinically relevant, considering that changes in lifestyle and potential pharmacological intervention could reduce the risk of advancing into T2D and favor regression to euglycemia [10,11].”
BackgroundPrediabetes Awareness and Practice Among Indian Doctors– A Cross-sectional Study
Basavareddy, A., Dass, A. S., & Sarala, N. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/13391.6290 · Cited by 7
H-FABP: A beacon of hope for prediabetic heart disease
Ramesh, P., Chauhan, A., Goyal, P., & Singh, A. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_296_20 · Cited by 4
“An estimated 34% of adults worldwide have pre diabetes and it is also recognized as a reversible condition with improvement in lifestyle and activity.[1]”
BackgroundRegidor, E., Soriano, L. C., Ruíz, A., Goday, A., Carabantes-Alarcón, D., Díez‐Espino, J., Artola, S., Franch‐Nadal, J., & for the PREDAPS Study Group (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.1958497 · Cited by 4
“to recommend behavioral modifications even in people with FPG or HbA1c values below these cutoffs [13,14,26].”
BackgroundInsights to the emerging potential of glucokinase activators as antidiabetic agent
Mehra, A., Kumar, S., Mittal, A., Kohli, R., & Mittal, A. (2024) · Pharmaceutical Patent Analyst · doi:10.1080/20468954.2024.2389762 · Cited by 5
The Application of Mulberry Elements into a Novel Form of Easy-to-Prepare Dried Smoothie
Przeor, M., Mhanna, N. I. A., Drożdżyńska, A., & Kobus‐Cisowska, J. (2024) · Applied Sciences · doi:10.3390/app142210432 · Cited by 6
Covid-19 and Diabetes: Mini-review
Lopez, A. P. (2020) · Obesity and Diabetes Research · doi:10.47275/2692-0964-101 · Cited by 4
A new Brazilian regional scenario of Type 2 diabetes risk in the next ten years
Nascimento, L. G., do Nascimento, R. C. R. M., Frade, J. C. Q. P., Pinheiro, E. B., Ferreira, W. M., Reis, J. S., Melo, K., Pontarolo, R., Lenzi, M. S. A., de Almeida, J. V., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.07.011 · Cited by 5
Current pharmacotherapy options for type 2 diabetes
Habtemariam, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102922-0.00005-5 · Cited by 7
Health Literacy and Blood Glucose Level in Transitional Albania
Dika, Q., Duli, M., Burazeri, G., Toçi, D., Brand, H., & Toçi, E. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00405 · Cited by 5
“As the levels of blood glucose fluctuate greatly during everyday life activities (5), health behavior becomes sensibly relevant for the prevention of diabetes in the general population (6) and especially important in the management of diabetes in terms of diet, physical activity, monitoring blood glucose levels, medic…”
BackgroundWeijdijk, L. P. M., Thomassen, T. M. J. A., de Keyzer, N. C., Mayer, E., Valkenburg, C., van der Weijden, G. A., & Slot, D. E. (2025) · International Journal of Dental Hygiene · doi:10.1111/idh.70003 · Cited by 4
“As prediabetes may be reversible [88], data regarding this condition were excluded.”
Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach
Fuggle, N., Rannou, F., Maheu, E., Migliore, A., Al-Daghri, N., Alokail, M. S., Ammann, P., Berenbaum, F., Bemden, A. B., Brandi, M. L., et al. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-026-03366-8 · Cited by 4
“This concept is well-estab - lished in some disease areas, with impaired glucose tolerance identified prior to the development of diabetes mellitus [ 15 ], with hypercholesterolaemia treated to improve cardio-vascular risk [ 16], and with early inflammatory arthritis clin - ics aiming to identify…”
Fournier, C., Karagounis, L. G., Sacco, S. M., Horcajada, M.-N., Decaens, T., Offord, E., Bouzakri, K., & Ammann, P. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108952 · Cited by 3
Sharma, N., Mariam, W., Basu, S., Shrivastava, R., Rao, S., Sharma, P., & Garg, S. (2023) · Cureus · doi:10.7759/cureus.34826 · Cited by 4
“Evidence-based research suggests that lifestyle changes such as a healthy diet and physical activity improve glycemic and blood pressure, reduce the risk of complications, and enhance the quality of life of patients with DM and HTN [21,22].”
BackgroundKnowledge, Attitude, Practice, and Barriers Regarding Prediabetes Among Adults in Saudi Arabia
Alsalman, R. A., Alsharari, A. J., AlmohammedAli, A. N., Alzahrani, A. F., Alghamdy, B. S., Alzibali, N., Alshamrani, R. K., Al-Beladi, R. Z., Alasmari, W. A., Jadoh, W., et al. (2024) · Cureus · doi:10.7759/cureus.67699 · Cited by 3
“Prediabetes is now thought to be reversible; lifestyle changes and other interventions can be successfully implemented during the prediabetes phase to avoid the development of T2DM [4].”
BackgroundBun, R. S., Tounkara, B. S., Leruste, S., Kichenapanaidou, L., Simonson, M., Kowalczyk, C., Franco, J.-M., Marimoutou, C., & Nobécourt, E. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102893 · Cited by 3
“Modification of lifestyle habits are the cornerstone to avoid evolution from prediabetes to diabetes (Skoglund et al., 2022 Mar 21; Tuso, 2014).”
BackgroundCarvalho-Azevedo, A., Abbate, M., Fresneda, S., Arias-Fernández, M., Torres-Carballo, M., Yáñez, A. M., Moreno, C., & Bennasar‐Veny, M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1591205 · Cited by 4
Teoh, K. W., Ng, C. M., Chong, C. W., Ng, Y. L., Bell, J. S., & Lee, S. W. H. (2025) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2025.10.002 · Cited by 4
Srugo, S. A., de Groh, M., Jiang, Y., MORRISON, H. I., & Villeneuve, P. J. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.01.002 · Cited by 6
Chandrasekaran, D., Sathya, R., Rao, G. N., Rachel, J. B., Harishini, B., & Daniel, T. D. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_558_20 · Cited by 3
“[9,13,14] Group 3 – (nondiabetics) having blood sugar and HbA1c within the normal limits which is in between 120 and 140 mmHg and HbA1c below 6.5 mmol.”
InfluentialKhanna, D., Bhatt, J., Gupta, J., Sethi, S., Joshi, P., Pareek, M., & Agrawal, D. (2023) · Food and Nutrition Sciences · doi:10.4236/fns.2023.1410060 · Cited by 3
Mathur, P., Saxena, S., Saxena, B., & Rani, V. (2024) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257265947231129074526 · Cited by 3
Al‐Omar, H. A., Czech, M., Nam, T. Q., Gottwald‐Hostalek, U., Vesic, N., Whitehouse, J. M., & Dawson, M. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13553 · Cited by 2
Characteristics and risk factors associated with developing prediabetes in Saudi Arabia
Tourkmani, A. M., Alharbi, T., Rsheed, A. M. B., Alotaibi, A., Eissa, M. S. A., Youzghadli, I. M., AlRuthia, Y. S., & Alrasheedy, A. A. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2413922 · Cited by 3
“…important, as current evidence shows that it may decrease the risk of transition from predia-betes to full-blown diabetes for as long as 10 years [20]. in addition, it is essential to address the risk factors in healthy individuals, such as overweight and obesity, to prevent the development of…”
BackgroundZhang, J., Dashtbozorg, B., Huang, F., Tan, T., & Romeny, B. M. T. H. (2018) · Computer Methods in Biomechanics and Biomedical Engineering Imaging & Visualization · doi:10.1080/21681163.2018.1519851 · Cited by 3
“In the late stage of diabetes, medical treatment is no longer effective to cure the disease, while patients can still be controlled from the early diabetes in time (Tuso 2014).”
BackgroundSinclair-White, B. M., Nett, B., Ilagan, L., Cacal, S. L., Vu, U., Ching, L. K., Pirkle, C. M., & Keliikoa, L. B. (2020) · PubMed Central · Cited by 3
Carotid Bodies: Use of Chemosensitivity as a Biomarker in Prediabetes
Conde, S. V., Lages, M., Guarino, M. P., & Sacramento, J. F. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_38 · Cited by 3
Effect of a 6-month yoga intervention on heart rate variability among pre-diabetics.
Saboo, N., & Kacker, S. (2022) · PubMed Central · Cited by 10
Zilov, A. V., & Болиева, Л. З. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-128 · Cited by 2
Tao, X., Guan, Z., Qu, J., Sun, Q., Xiao, Y., Li, Z., Ma, N., Lin, X., Wen, G., Zheng, H., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07582-8 · Cited by 2
“These early perturbations are potentially reversible but frequently progress without timely, targeted intervention [7 ].”
Sharma, P., Dilip, T. R., Sharma, V., & Kulkarni, A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01790-7 · Cited by 2
“As the earliest clinically identifiable stage of dysglycemia, prediabetes offers a critical window for prevention, wherein timely management of risk factors can significantly alter disease trajectory [23, 26, 29–36].”
Toward a roadmap for addressing today's health dilemma–The 101-statement consensus report
Wirnitzer, K., Motevalli, M. S., Tanous, D., Drenowatz, C. J., Moser, M., Cramer, H., Rosemann, T. J., Wagner, K., Michalsen, A., Knechtle, B., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1676080 · Cited by 4
“…by integrating all areas of lifestyle medicine, with a particular focus on the two main pillars of sustainable health–“Healthy Eating & Active Living”– forms the minimum recommendation to start one’s engagement toward better health behaviors, habits, and patterns (Figure 3) (13–15 , 165– 172).”
InfluentialSalmon, M. K., Gordon, N. F., Constantinou, D., Reid, K. S., Wright, B. S., Kridl, T. L., & Faircloth, G. C. (2021) · American Journal of Lifestyle Medicine · doi:10.1177/15598276211019012 · Cited by 2
“However, it is hypothesized that normal weight individuals develop type 2 diabetes through different pathophysiological mechanisms and that methods of prevention may differ in the absence of overweight or obesity.(4) While lifestyle intervention is the foundation of diabetes prevention programs, with the exception of…”
BackgroundAmeliorating Prediabetes With Healthy Lifestyles: A Stage-Tailored Motivational Interviewing Pilot
Kao, T. A., Born, A. L., & Ling, J. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2021.04.003 · Cited by 4
Bogaert, L., Willems, I., Calders, P., Dirinck, E. L., Kinaupenne, M., Decraene, M., Lapauw, B., Strumane, B., Daele, M. V., Verbestel, V., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102995 · Cited by 3
Khunlertkit, T., Viangteeravat, T., Wangprapa, P., Siriwechdaruk, S., Ford, J. M., & Pongpirul, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302438 · Cited by 2
Opinion of doctors about unmet needs of rural diabetics
Dixit, R. R., & Pokala, N. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20160111 · Cited by 2
Evaluación del consumo de macronutrientes y micronutrientes por individuos prediabéticos
Schlickmann, D. D. S., Molz, P., Pereira, C. S., & Franke, S. I. R. (2022) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x202230020098 · Cited by 3
EFFECTIVENESS OF ZINC SUPPLEMENTATION FOR TYPE II DIABETES PREVENTION: A SYSTEMATIC REVIEW
Ridwan, A. S., Suryoadji, K. A., Rycko, N. S., & Wisnu, W. (2022) · BIMIKI (Berkala Ilmiah Mahasiswa Ilmu Keperawatan Indonesia) · doi:10.53345/bimiki.v10i2.322 · Cited by 1
“5,6,18 Due to the long duration of the disease course, research to see the effect of therapy should be carried out over a longer term, both the intervention period and the follow-up period.”
BackgroundPillay, M. T., Mosili, P., Akinnuga, A. M., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2023) · Diabetology · doi:10.3390/diabetology4030034 · Cited by 3
Proinsulin C-peptide-mediated signalling and the search for its receptor
Janabi, A. M. (2017) · Figshare · doi:10.13140/rg.2.2.30079.30888 · Cited by 5
Prediabetes in children and adolescents: A ticking bomb!
Gupta, A., Choudhary, N., & Gupta, N. (2024) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v13.i2.92127 · Cited by 3
Tripathi, P., Tiwari, D., KADAM, N. S., VYAWAHARE, A. R., Sharma, B., Kathrikolly, T., GANLA, M. H., & Saboo, B. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6172692 · Cited by 3
“By restoring healthy glucose concentrations, the onset of T2D and its complications can be delayed or prevented [10].”
Electronic nose for detecting abnormal glucose metabolism in heart transplant recipients
Wijbenga, N., Muntinga, A. J., Goedendorp-Sluimer, M. M., van Dijk, B. C. J., Roest, S., Brugts, J. J., Çalişkan, K., Constantinescu, A. A., Zandbergen, A. A. M., Bos, D., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02970-8 · Cited by 1
“In patients with prediabetes, lifestyle intervention may decrease the risk of prediabetes progressing to diabetes for as long as 10 years [4, 8], nearly the median survival post-HTx.”
Youssef, M. I., Dasumani, M., Maina, R., Radwan, A., & Gathungu, D. K. (2025) · Fractal and Fractional · doi:10.3390/fractalfract9120820 · Cited by 1
Rehana Bind, A., Madhavanpillai, B. R., Nafeesa, R. B., & Kumar, S. S. (2025) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_473_24 · Cited by 1
“[12] Prediabetes is a risk state that defines a high likelihood for developing DM and is a reversible condition, unlike DM. [13] DM can be prevented if the prediabetic stage is identified and treated effectively.”
Lee, J. H., Kim, H. J., & Lee, K. H. (2026) · Nutrients · doi:10.3390/nu18040682 · Cited by 1
“Additionally, approximately 5–10% of people worldwide with PD progress to diabetes annually, and approximately 37% and 70% of individuals may be at high risk of developing type 2 diabetes mellitus (T2DM) or related complications within four and ten years, respectively [6,7].”
Asharani, P. V., Roystonn, K., Ramu, M., Wee, B. T. Y., Devi, F., Shah, I., Wang, P., Lum, A., Fang, S. C., Lee, E. S., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-108846 · Cited by 1
“(41–60 years, male) Feeling unheard: the healthcare (HC) team related barriers to care”
Evaluation in Diagnosis and Management of Diabetic Neuropathy
Zadeh, W. W., & Thanupakorn, P. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115027 · Cited by 2
“An estimated 37% of prediabetic individuals may develop diabetes within four years, however, with interventions such as diet, exercise and BMI control, that percentage could decrease to 20% [19].”
BackgroundCarotid Bodies:Use of Chemosensitivity as a Biomarker in Prediabetes
Conde, S. V., Lages, M., Guarino, M. P., & Sacramento, J. F. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_38-1 · Cited by 4
Prediabetes awareness among different specialities of physicians: A review
Mohsina Hyder, K., Balasubrmaniam, V., Rajanandh, M. G., & Ponnusankar, S. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120920 · Cited by 2
“We need to develop a national registry of patients who have prediabetes similar to the other diseases and need to have a thorough follow-up of these patients at least annually (Tuso, 2014).”
BackgroundDeng, L., Liu, H., Liu, W., Liao, Y., Liang, Q., & Wang, W. (2022) · PubMed Central · doi:10.11817/j.issn.1672-7347.2022.220085 · Cited by 1
Kamble, S. D., Yeola, G., & Gaikwad, P. P. (2023) · Journal of Research in Ayurvedic Sciences · doi:10.4103/jras.jras_135_23 · Cited by 1
Aljehani, F. (2024) · Cureus · doi:10.7759/cureus.69300 · Cited by 3
Bhasin, G., Dafale, R. S., Annapoorna, K., Kamath, S. U., Matlani, D., Rana, R., Prabhu, M. M., Pandey, A. K., Shetty, S., Shetty, L., et al. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101493 · Cited by 3
“This approach aligns with the early-stage nature of pre-diabetes, which typically requires moderate-intensity physical activity and can reduce the risk of T2DM [35].”
Huang, C., Zhang, Y., Yang, X., Li, G., & Gao, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1502861 · Cited by 1
“Up to 37% of untreated prediabetes cases may progress to type 2 diabetes within four years, but early intervention to restore normoglycemia can substantially reduce cardiovascular risks (4, 5).”
Curiaki, G., Gonzáléz, A. D., Cabrera, M. A. S., Guidoni, C. M., & Girotto, E. (2020) · Revista Colombiana de Ciencias Químico Farmacéuticas · doi:10.15446/rcciquifa.v49n1.85168 · Cited by 1
Davis, L. C. (2020) · Fashion Style & Popular Culture · doi:10.1386/fspc_00030_1
Bustomi, S., Waris, L., & Siswati, D. T. (2023) · KnE Social Sciences · doi:10.18502/kss.v8i14.13841
“This is because prediabetes already experience insulin resistance [3,9,10] which causes blood glucose levels to be higher than normal.”
BackgroundInfluentialPrediabetes, diabetes mellitus, and anti‐diabetic treatment: Is anyone still healthy?
Jonnalagadda, V. G., Char, H. P., & Samudrala, P. K. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3009 · Cited by 1
“In general, prediabetic individuals can be normolized by changing lifestyle modifications and drug‐based interventions.(3-6) In the available treatment options, metformin is a prototype of the drug due to its widespread availability and safety profile in different individuals.”
Background
Metadata
- Authors
- Tuso, P.
- Affiliations
- Care Management Institute Physician Lead for Total Health..
- Corresponding author
- Tuso, Phillip
- Venue
- The Permanente Journal
- Publisher
- The Permanente Federation
- Published
- 2014-09
- Volume
- 18
- Issue
- 3
- Pages
- 88-93
- ISSN
- 1552-5767 (ISSN-L)
- 1552-5775
- PMC
- PMC4116271
- OpenAlex
- W2031370419
- Cited by
- 252
- References
- 46
- Citations by year
- 2026: 11 · 2025: 27 · 2024: 23 · 2023: 24 · 2022: 30 · 2021: 35 · 2020: 37 · 2019: 24 · 2018: 16 · 2017: 9 · 2016: 9 · 2015: 5 · 2014: 2
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Permanente Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, type 2 diabetes prevention, lifestyle modification, lifestyle intervention, overweight, physical inactivity, risk stratification, Diabetes Prevention Program, cost-effectiveness, return on investment, blood glucose
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Obesity, Patient Education as Topic, Prediabetic State, Risk Factors, United States, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.